One drug, many targets: Finding molecular targets of an HIV drug used in cancer therapy
Thursday, April 28, 2011 - 17:00
in Health & Medicine
Researchers at the University of California, San Diego and Hunter College of the City University of New York (CUNY) have identified potential human molecular targets of the anti-HIV drug Nelfinavir, which may explain why the drug is also effective as a cancer therapy. Their study will be published in the online edition of PLoS Computational Biology on April 28.
